The Influences of Endostatin on Bladder Tumor Growth and Its Mechanism

侯树坤,杜志军,王晓峰,闫征,顾永鹏,叶海云

DOI: https://doi.org/10.3760/j:issn:1000-6702.2002.10.004

2002-01-01

Abstract:Objective To evaluate the inhibitory effect of endostatin on bladder tumor and to investigate the possible mechanism of the inhibition. Methods (1)By means of MTT method,the effects of endostatin on ECV304 and EJ cells proliferation were studied.(2)Ten nude mice were subcutaneously implanted with EJ bladder tumor cells (1×10 7/ml). After the tumor volume exceeded 100～200 mm 3,the mice were randomized into two groups.One group received recombinant human endostatin (2 mg·kg -1 ·d -1 ) whereas the other group received PBS as control.All the treatment lasted 21 days.(3) After that,the mice were sacrificed and then MMPs and TIMPs mRNA expression were measured in implanted tumor by RT PCR and Western blot method. Results (1)Endostatin inhibits ECV304 proliferation stimulated with bFGF (5 ng/ml).In addition,we report for the first time that endostatin also inhibits EJ cells proliferation.(2)The mean tumor weight of endostatin treated group (0.70±0.16 g) was significantly lower than that of control group (1.14±0.21)g, P 0.05.(3)MMP 9 mRNA expression was inhibited in endostatin treated group,but MMP 2,TIMP 2 and MT1 MMP mRNA were not influenced. Conclusions These results demonstrate that endostatin has its antitumor effects on bladder carcinomas,and that at least in part,the important mechanisms of endostatin action on the potent antiangiogenic and antitumor activities involves regulating the MMPs,TIMPs expression.